Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation

"No one … is entitled to sell the government drugs at prices the government won't agree to pay," Judge Colm Connolly wrote.

March 5, 2024 Check out STAT+

Sponsored By

ANDREW YATES/AFP via Getty Images STAT+ | Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation A federal judge on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare's new drug price negotiation program. By Rachel Cohrs STAT+ | Massachusetts lawmakers consider $1 billion proposal to bolster region's life science leadership Massachusetts Governor Maura Healey proposes $1 billion investment in life sciences over next decade, but lawmakers are cautious. By Robert Weisman — Boston Globe STAT+ | Longer treatment gave better liver outcomes for MASH patients, Akero drug study shows Patients treated longer with the drug, efruxifermin, saw sustained reductions in the liver scarring that characterizes MASH. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser